
	Mr. Craig W. Carlson has been Chief Financial Officer of Hana Biosciences, Inc. since April 1, 2010 and serves as its Senior Vice President. Mr. Carlson served as Vice President of Talon Therapeutics, Inc. since March , 2010. He served as Vice President, Finance and Chief Financial Officer of Neurobiological Technologies Inc. from July 31, 2006 to March 31, 2008 and also served its Principal Accounting Officer until March 31, 2008. He has more than 27 years of experience in finance and communications. From December 2005 until joining Neurobiological Technologies, he was employed as a business consultant, primarily focused on advising a private biotechnology company. Mr. Carlson was employed with Cygnus Inc., where he served as the Chief Financial Officer from 1998 to 2005 and Chief Operating Officer from December 2000 to 2005, beginning in 1993 until Neurobiological Technologies Inc.&#39;s acquisition by Animas in 2005 and served as its Senior Vice President and Principal Accounting Officer. He served as Chief Financial Officer and Chief Operating Officer of 20 Cent Ventures from February 2009 to February 2010. Mr. Carlson joined Cygnus in July 1993 as Vice President of Corporate Communications, and served as its Vice President, Strategic Planning and Corporate Marketing, then assumed responsibility for finance and information technology in 1997 as Senior Vice President, Finance. From 1988 to 1993, he served as Vice President and Group Director at Young &amp; Rubicam Advertising in San Francisco. He spent 14 years developing and implementing marketing and communications strategies for major corporations. He serves as Director of Orthogene, Inc. Mr. Carlson has an MBA degree from Stanford University, an M.S. degree in Education and Counseling from Hofstra University and a BA degree in Political Science from Union College in Schenectady, New York.
